Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A G Turpie

Showing results (151-160 of 178) with videos related to

Pageof 18
Sort By:
Lancet (London, England)|June 3, 1989
The Canadian American Ticlopidine Study (CATS) in thromboembolic strokeM Gent, J A Blakely, J D Easton, et al.
The New England Journal of Medicine|September 9, 1999
A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study GroupM M Samama, A T Cohen, J Y Darmon, et al.
Circulation|January 1, 1996
Low-molecular-weight heparinoid orgaran is more effective than aspirin in the prevention of venous thromboembolism after surgery for hip fractureM Gent, J Hirsh, J S Ginsberg, et al.
The New England Journal of Medicine|August 14, 1997
A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study GroupM Cohen, C Demers, E P Gurfinkel, et al.
Lancet (London, England)|March 7, 1987
Double-blind randomised trial of Org 10172 low-molecular-weight heparinoid in prevention of deep-vein thrombosis in thrombotic strokeA G Turpie, M N Levine, J Hirsh, et al.
The American Journal of Cardiology|September 16, 1998
Low-molecular-weight heparins in non-ST-segment elevation ischemia: the ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin versus intravenous unfractionated heparin, in non-Q-wave Coronary EventsM Cohen, C Demers, E P Gurfinkel, et al.
The New England Journal of Medicine|February 9, 1989
Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarctionA G Turpie, J G Robinson, D J Doyle, et al.
Stroke|October 1, 1988
The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Design, organization, and baseline resultsM Gent, J A Blakely, J D Easton, et al.
Annals of Internal Medicine|December 29, 1998
Use of a clinical model for safe management of patients with suspected pulmonary embolismP S Wells, J S Ginsberg, D R Anderson, et al.
Annals of Internal Medicine|December 29, 1998
Sensitivity and specificity of a rapid whole-blood assay for D-dimer in the diagnosis of pulmonary embolismJ S Ginsberg, P S Wells, C Kearon, et al.
Pageof 18

Showing results (151-160 of 178) with videos related to

Sort By:
Pageof 18
Lancet (London, England)|June 3, 1989
The Canadian American Ticlopidine Study (CATS) in thromboembolic strokeM Gent, J A Blakely, J D Easton, et al.
The New England Journal of Medicine|September 9, 1999
A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study GroupM M Samama, A T Cohen, J Y Darmon, et al.
Circulation|January 1, 1996
Low-molecular-weight heparinoid orgaran is more effective than aspirin in the prevention of venous thromboembolism after surgery for hip fractureM Gent, J Hirsh, J S Ginsberg, et al.
The New England Journal of Medicine|August 14, 1997
A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study GroupM Cohen, C Demers, E P Gurfinkel, et al.
Lancet (London, England)|March 7, 1987
Double-blind randomised trial of Org 10172 low-molecular-weight heparinoid in prevention of deep-vein thrombosis in thrombotic strokeA G Turpie, M N Levine, J Hirsh, et al.
The American Journal of Cardiology|September 16, 1998
Low-molecular-weight heparins in non-ST-segment elevation ischemia: the ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin versus intravenous unfractionated heparin, in non-Q-wave Coronary EventsM Cohen, C Demers, E P Gurfinkel, et al.
The New England Journal of Medicine|February 9, 1989
Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarctionA G Turpie, J G Robinson, D J Doyle, et al.
Stroke|October 1, 1988
The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Design, organization, and baseline resultsM Gent, J A Blakely, J D Easton, et al.
Annals of Internal Medicine|December 29, 1998
Use of a clinical model for safe management of patients with suspected pulmonary embolismP S Wells, J S Ginsberg, D R Anderson, et al.
Annals of Internal Medicine|December 29, 1998
Sensitivity and specificity of a rapid whole-blood assay for D-dimer in the diagnosis of pulmonary embolismJ S Ginsberg, P S Wells, C Kearon, et al.
Pageof 18